HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ocular surface and MUC5AC alterations in atopic patients with corneal shield ulcers.

AbstractPURPOSE:
To describe MUC5AC alterations and the ocular surface disorder in atopic patients with or without corneal ulcers.
METHODS:
Atopic patients' eyes were divided into two groups according to the presence and absence of corneal ulceration. The subjects underwent corneal sensitivity measurements, Schirmer test, tear film break-up time (BUT), fluorescein and Rose Bengal staining of the ocular surface and conjunctival impression cytology and brush cytology. Impression cytology samples underwent PAS and immunohistochemical staining for MUC5AC. Brush cytology specimens underwent evaluation for inflammatory cell expression and quantitative real-time PCR for MUC5AC mRNA expression. The differences related to the tear function and ocular surface examination parameters between patients with and without corneal ulceration and healthy control subjects were studied. In addition, the differences of the study parameters related to ocular surface epithelial health and inflammatory status between patient eyes with atopic keratoconjunctivitis (AKC) and vernal keratoconjunctivitis (VKC) were investigated.
RESULTS:
The mean corneal sensitivity and BUT values were significantly lower in atopic patients with corneal ulcers, compared to patients without ulcers and controls (p < 0.001). Brush cytology specimens from patients with corneal ulcers revealed significantly higher expression of inflammatory cells compared to patients without ulcers and controls (p < 0.001). Impression cytology samples from eyes with corneal ulcers showed significant squamous metaplasia and reduction in goblet cell density compared to eyes without ulcers and eyes of control subjects. The mean squamous metaplasia grade was significantly higher in eyes with AKC compared to eyes with VKC (p < 0.02). The mean goblet cell density was significantly lower in eyes with AKC compared to eyes with VKC (p < 0.01). Specimens from eyes with corneal ulcers showed PAS positive mucin pickup and did not stain positive for MUC5AC. MUC5AC mRNA expression was significantly lower in eyes with corneal ulcers compared to eyes without ulcers and eyes of control subjects. MUC5AC mRNA expression was also significantly lower in eyes with AKC compared to eyes with VKC.
CONCLUSIONS:
Ocular surface inflammation, tear film instability, and decreased conjunctival MUC5AC mRNA expression were thought to be important in the pathogenesis of noninfectious corneal shield ulcers in atopic ocular surface disease.
AuthorsMurat Dogru, Naoko Asano-Kato, Mari Tanaka, Ayako Igarashi, Shigeto Shimmura, Jun Shimazaki, Naoko Okada, Yoji Takano, Kazumi Fukagawa, Kazuo Tsubota, Hiroshi Fujishima
JournalCurrent eye research (Curr Eye Res) Vol. 30 Issue 10 Pg. 897-908 (Oct 2005) ISSN: 0271-3683 [Print] England
PMID16251127 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • MUC5AC protein, human
  • Mucin 5AC
  • Mucins
  • RNA, Messenger
Topics
  • Adolescent
  • Adult
  • Case-Control Studies
  • Child
  • Conjunctiva (pathology)
  • Cornea (physiopathology)
  • Corneal Ulcer (etiology, metabolism, pathology, physiopathology)
  • Female
  • Goblet Cells (pathology)
  • Humans
  • Hypersensitivity (complications, metabolism, pathology, physiopathology)
  • Immunohistochemistry
  • Male
  • Metaplasia
  • Mucin 5AC
  • Mucins (genetics, metabolism)
  • Periodic Acid-Schiff Reaction
  • Physical Stimulation
  • RNA, Messenger (metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sensation
  • Staining and Labeling
  • Tears (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: